JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2014, 63(3):127-135 | DOI: 10.36290/csf.2014.026

Impact of formulation and process parameters on the properties of chitosan-based microspheres prepared by external ionic gelation

Romana Kubánková, Jakub Vysloužil, Martina Kejdušová, David Vetchý, Kateřina Dvořáčková*
Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav technologie léků, Brno

The aim of this experimental study was to optimize a preparation of microspheres from high viscosity chitosan by external ion gelation and to evaluate selected aspects of their preparation. For drug-free microparticles, the concentration of chitosan dispersions was chosen as a formulation variable; the position of instrument for a dispersion extrusion (horizontal vs. vertical) was evaluated as a process variable. On the basis of sphericity and equivalent diameter results, three different concentrations of chitosan dispersions were used for 5-aminosalicylic acid (5-ASA) encapsulation with the extrusion instrument in horizontal position, which was considered as the optimal. In consequent drug-loaded microparticle preparation, the influence of the concentration of chitosan dispersions and composition of hardening solution (10% sodium tripolyphosphate (TPP) vs. 10% TPP containing drug) was evaluated. In prepared 5-ASA microspheres it was found that the equivalent diameter increased with increasing chitosan concentration. In the case of sphericity, significant differences were not found. Samples prepared with the drug in both chitosan dispersion and hardening solution had a higher drug content, a smaller equivalent diameter and they showed a faster in vitro drug release in comparison with the samples prepared with the drug in chitosan dispersion only.

Keywords: microparticles; external ionic gelation; chitosan; formulation and process parameters; dissolution profile

Received: May 21, 2014; Accepted: May 30, 2014; Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kubánková R, Vysloužil J, Kejdušová M, Vetchý D, Dvořáčková K. Impact of formulation and process parameters on the properties of chitosan-based microspheres prepared by external ionic gelation. Čes. slov. farm. 2014;63(3):127-135. doi: 10.36290/csf.2014.026.
Download citation

References

  1. Park J., Ye M., Park K. Biodegradable polymers for microencapsulation of drugs. Molecules 2005; 10, 146-161. Go to original source... Go to PubMed...
  2. Yen M. T., Yang J. H., Mau J. L. Antioxidant properties of chitosanu from crab shells. Carbohydr. Polym. 2008; 74, 840-844. Go to original source...
  3. Croisier F., Jérôme Ch. Chitosan-based biomaterials for tissue engineering. Eur. Polym. J. 2013; 49, 780-792. Go to original source...
  4. Singla A. K., Chawla M. Chitosan: some pharmaceutical and biological aspects - an update. J. Pharm. Pharmacol. 2001; 53, 1047-1067. Go to original source... Go to PubMed...
  5. Ilium L. Chitosan and its use as a pharmaceutical excipient. Pharmaceut. Res. 1998; 15, 1326-1331. Go to original source... Go to PubMed...
  6. Meng-Lund E., Muff-Westergaard Ch., Sander C., Madelung P., Jacobsen J. A mechanistic based approach for enhancing buccal mucoadhesion of chitosanu. Int. J. Pharm. 2014; 461, 280-285. Go to original source... Go to PubMed...
  7. Bravo-Osuna I., Vauthier Ch., Farabollini A., Palmieri G. F., Ponchel G. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials 2007; 28, 2233-2243. Go to original source... Go to PubMed...
  8. Yang T. C., Chou C. C., Li C. F. Antibacterial aktivity of N-alkylated disacharide chitosan derivatives. Int. J. Food Microbiol. 2005; 97, 237-245. Go to original source... Go to PubMed...
  9. Dehghani F., Hoseini M. H. M., Memarnejadian A., Yeganeh F., Rezaie A. M., Khaze V., Sattari M., Darbandi Tamijani H., Labibi F., Mossaffa N. Immunomodulatory activities of chitin microparticles on Leishmania major-infected murine macrophages: interaction with a bacterial membrane model. Arch. Med. Res. 2011; 42, 572-576. Go to original source... Go to PubMed...
  10. Baldrick P. The safety of chitosan as a pharmaceutical excipient. Regul. Toxicol. Pharm. 2010; 56, 290-299. Go to original source... Go to PubMed...
  11. Evans J. R., Davids W. G., MacRae J. D., Amirbahman A. Kinetics of kadmium uptake by chitosan-based crab shells. Water Res. 2002; 36, 3219-3226. Go to original source... Go to PubMed...
  12. Pusateri A. E., McCarthy S. J., Gregory K. W., Harris R. A., Cardenas L., McManus A. T., Goodwin C. W. Effect of a chitosan-based hemostatic dressing on blood loss and survival in a model of severe velus hemorrhage and hepatic injury in swine. J. Trauma 2003; 54, 177. Go to original source... Go to PubMed...
  13. Wassmer S., Rafat M., Fong W. G., Baker A. N., Tsilfidis C. Chitosan microparticles for delivery of proteins to the retina. Acta Biomater. 2013; 9, 7855-7864. Go to original source... Go to PubMed...
  14. Keegan G. M., Smart J. D., Ingram M. J., Barnes L.-M., Burnett G. R., Rees G. D. Chitosan microparticles for the controlled delivery of fluoride. J. Dent. 2012; 40, 229-240. Go to original source... Go to PubMed...
  15. Bajerová M., Gajdziok J., Dvořáčková K., Masteiková R., Rabišková M. Metody přípravy mikročástic ve farmaceutické technologii. Čes. slov. Farm. 2009; 58, 191-199.
  16. Lamprecht A., Torres H. R., Schäfer U., Lehr C. M. Biodegradable microparticles as a two-drug controlled release formulation: a potential treatment of inflammatory bowel disease. J. Control. Release 2000; 69, 445-454. Go to original source... Go to PubMed...
  17. Rabišková M., Bautzová T., Gajdziok J., Dvořáčková K., Lamprecht A., Pellequer Y., Spilková J. Coated chitosanu pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation. Int. J. Pharm. 2012; 422, 151-159. Go to original source... Go to PubMed...
  18. Garekani H. A., Moghaddam Z. F., Sadeghi F. Organic solution versus aqueous dispersion of Eudragit RS in preparation of sustained release microparticles of theophylline using spray drying. Colloid Surface B. 2013; 108, 374-379. Go to original source... Go to PubMed...
  19. Vysloužil J., Kejdušová M., Dvořáčková K., Vetchý D. Influence of formulation and process parameters on the characteristics of P LGA-based microparticles with controlled drug release. Čes. slov. Farm. 2013; 62, 120-126.
  20. Bajerová M., Dvořáčková K., Gajdziok J., Masteiková R. Mikročástice na bázi oxycelulosy - vliv procesních proměnných na enkapsulační účinnost. Čes. slov. Farm. 2010; 59, 67-73.
  21. Shu X. Z., Zhu K. J. A novel approach to prepare tripolyphosphate/chitosanu komplex beat for controlled release drug delivery. Int. J. Pharm. 2000; 201, 51-58. Go to original source... Go to PubMed...
  22. Mi F. L., Sung H. W., Shyu S. S., Su C. C., Peng C. K. Synthesis and characterization of biodegradable TPP/genipin co-crosslinked chitosan gel beads: a new matrix for controlled release of pindolol. Polymer 2003; 44, 6521-6530. Go to original source...
  23. Lemoine D., Wauters F., Bouchend'homme S., Préat V. Preparation and characterization of alginate microspheres containing a model antigen. Int. J. Pharm. 1998; 176, 9-19. Go to original source...
  24. Narra K., Dhanalekshmi U., Rangaraj G., Raja D., Kumar C. S., Reddy P. N., Mandal A. B. Effect of formulation variables on rifampicin loaded alginate beads. Iran. J. Pharm. Res. 2012; 11, 715-721.
  25. Siso M. I. G., Lang E., Carrenõ-Gómez B., Becerra M., Espinar F. O., Méndez J. B. Enzyme encapsulation on chitosan microbeads. Process Biochem. 1997; 32, 211-216. Go to original source...
  26. Chan E.-S., Lee B.-B., Ravindra P., Poncelet D. Prediction models for shape and size of ca-alginate macrobeads produced through extrusion-dripping method. J. Colloid Interf. Sci. 2009; 338, 63-72. Go to original source... Go to PubMed...
  27. Patel Y. L., Sher P., Pawar A. P. The effect of drug concentration and curing time on processing and properties of calcium alginate beads containing metronidazole by response surface metodology. AAPS Pharm. Sci. Tech. 2006; 7, E24-E30. Go to original source... Go to PubMed...
  28. 5-Aminosalicylic acid.: Santa Cruz Biotech [online]. [cit. 2013-08-18]. Dostupné z: http://www.scbt.com/datasheet-202890-5-aminosalicylic-acid.html.
  29. Smýkalová I., Horáček J., Hýbl M., Bjelková M., Pavelek M., Krulikovská T., Hampel D. Posuzování tvarových a barevných charakteristik semen modelových plodin i v korelaci s jejich obsahovými látkami. Chem. Listy 2011; 105, 138-145.
  30. Desai K. G. H., Park H. J. Preparation and characterization of drug-loaded chitosan-tripolyphosphate microspheres by spray drying. Drug Develop. Res. 2005; 64, 114-128. Go to original source...
  31. Bajerová M., Dvořáčková K., Gajdziok J., Masteiková R. Mikročástice na bázi oxycelulosy - vliv procesních proměnných na enkapsulační účinnost. Čes. slov. Farm. 2010; 59, 67-73.
  32. Cho J., Heuzey M. C., Bégin A., Carreau P. J. Viscoelastic properties of chitosanu solutions: Effect of concentration and ionic strength. J. Food Eng. 2006; 74, 500-515. Go to original source...
  33. Mura C., Nácher A., Merino V., Merino-Sanjuán M., Manconi M., Loy G., Fadda A. M., Díez-Sales O. Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific delivery. Colloid Surface B. Biointerfaces 2012; 94, 199-205. Go to original source... Go to PubMed...
  34. Ouwerx C., Velings N., Mestdagh M. M., Axelos M. A. V. Physico-chemical properties and rheology of alginate gel beads formed with various divalent cations. Polym. gels Netw. 1998; 6, 393-408. Go to original source...
  35. Ko J. A., Park H. J., Hwang S. J., Park J. B., Lee J. S. Preparation and characterization of chitosanu microparticles intended for controlled drug delivery. Int. J. Pharm. 2002; 249, 165-174. Go to original source... Go to PubMed...
  36. Chen Ch. T., Maa J. R., Yang Y. M., Chang Ch. H. Drop formativ from flat tip nozzles in liquid-liquid systém. Int. Commun. Heat Mass 2001; 28, 681-692. Go to original source...
  37. Yeom S., Lee S. Y. Dependence of micro-drop generation performance on dispenser geometry. Exp. Therm. Fluid Sci. 2011; 35, 1565-1574. Go to original source...
  38. Lupo B., Maestro A., Porras M., Gutiérrez J. M., González C. Preparation of alginate microspheres by emulsification/internal gelation to encapsulate cocoa polyphenols. Food hydrocolloid. 2014; 38, 56-65. Go to original source...
  39. Das S., Chaudhury A., Ng K. Y. Preparation and evaluation of zinc-pectin-chitosanu composite particles for drug delivery to the colon: Role of chitosan in modifying in vitro and in vivo drug release. Int. J. Pharm. 2011; 406, 11-20. Go to original source... Go to PubMed...
  40. Shu X. Z., Zhu K. J. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. Int. J. Pharm. 2002; 233, 217-225. Go to original source... Go to PubMed...
  41. Smrdel P., Bogataj M., Zega A., Planinšek O., Mrhar A. Shape optimization and characterization of polysaccharide beads prepared by ionotropic gelation. J. Microencapsul. 2008; 25, 90-105. Go to original source... Go to PubMed...
  42. Sezer A. D., Akbuga J. Controlled release of piroxicam from chitosan beads. Int. J. Pharm. 1995; 121, 113-116. Go to original source...
  43. Berger J., Reist M., Mayer J. M., Felt O., Peppas N. A., Gurny R. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm. 2004; 57, 19-34. Go to original source... Go to PubMed...
  44. Nandi S., Winter H. H. Swelling behavior of partially cross-linked polymers: A ternary system. Macromolecules 2005; 38, 4447-4455. Go to original source...
  45. Aranaz I., Mengíbar M., Harris R., Paños I., Miralles B., Acosta N., Galed G., Heras Á. Functional characterization of chitin and chitosan. Curr. Chem. Biol. 2009; 3, 203-230. Go to original source...
  46. Vaghani S. S., Patel M. M., Satish C. S. Synthesis and characterization of pH-sensitive hydrogel composed of carboxymethyl chitosan for colon targeted delivery of ornidazole. Carbohyd. Res. 2012; 347, 76-82. Go to original source... Go to PubMed...
  47. Chiou S.-H., Wu W.-T., Huang Y.-Y., Chung T.-W. Effects of the characteristics of chitosan on controlling drug release of chitosan coated PLLA microspheres. J. Microencapsulation. 2001; 18, 613-625. Go to original source... Go to PubMed...
  48. Kouřil J., Vysloužil J., Kejdušová M., Dvořáčková K., Vetchý D. Možnosti ovlivnění obsahu léčiva a enkapsulační účinnosti chitosanových mikrosfér připravených procesem iontové gelace. Čes. slov. Farm. 2014; 63, 75-83. Go to original source...
  49. Williams C., Panaccione R., Ghosh S., Rioux K.: Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease. Therap. Adv. Gastroenterol. 2011; 4, 237-248. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.